|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Natsuizaka M, Omura T, Akaike T, Kuwata Y,
Yamazaki K, Sato T, Karino Y, Toyota J, Suga T and Asaka M:
Clinical features of hepatocellular carcinoma with extrahepatic
metastases. J Gastroenterol Hepatol. 20:1781–1787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen F, Sato K, Fujinaga T, Sonobe M,
Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T and Date
H: Pulmonary resection for metastases from hepatocellular
carcinoma. World J Surg. 32:2213–2217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu HH, Liu J, Lin YL, Luo WS, Chu YJ,
Chang CL, Jen CL, Lee MH, Lu SN, Wang LY, et al: The rs2296651
(S267F) variant on NTCP (SLC10A1) is inversely associated with
chronic hepatitis B and progression to cirrhosis and hepatocellular
carcinoma in patients with chronic hepatitis B. Gut. 65:1514–1521.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yau T, Chan P, Ng KK, Chok SH, Cheung TT,
Fan ST and Poon RT: Phase 2 open-label study of single-agent
sorafenib in treating advanced hepatocellular carcinoma in a
hepatitis B-endemic Asian population: Presence of lung metastasis
predicts poor response. Cancer. 115:428–436. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu GQ, Shi KQ, Yu HJ, He SY, Braddock M,
Zhou MT, Chen YP and Zheng MH: Optimal adjuvant therapy for
resected hepatocellular carcinoma: A systematic review with network
meta-analysis. Oncotarget. 6:18151–18161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ono T, Yamanoi A, El Assal Nazmy O, Kohno
H and Nagasue N: Adjuvant chemotherapy after resection of
hepatocellular carcinoma causes deterioration of long-term
prognosis in cirrhotic patients: Metaanalysis of three randomized
controlled trials. Cancer. 91:2378–2385. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Katsura Y, Wada H, Kobayashi S, Marubashi
S, Eguchi H, Tanemura M, Umeshita K, Wakasa K, Doki Y, Mori M and
Nagano H: [A case of complete response to interferon-alpha and S-1
combination therapy for multiple pulmonary recurrences of
hepatocellular carcinoma after hepatic resection]. Gan To Kagaku
Ryoho. 38:2487–2489. 2011.PubMed/NCBI
|
|
9
|
Oh YJ, Park YM, Kim BH, Kim MJ, Cho JH,
Cha CW, Park SJ and Yeon JW: A case of hepatocellular carcinoma
with pulmonary metastases treated successfully with a combination
of repeated hepatic arterial infusion epirubicin and Cisplatin
chemotherapy and systemic low-dose infusion of 5-Fluorouracil. Gut
Liver. 3:343–348. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kilickap S, Kars A, Hamaloglu E and Simsek
H: A case of recurrent metastatic hepatocellular cancer controlled
with immunotherapy and antiviral therapy following resection. Med
Oncol. 26:501–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka K, Yamada K, Sasaki H, Kishi K,
Noura S, Takachi K, Eguchi H, Miyashiro I, Ohue M, Ohigashi H, Yano
M, Ishikawa O and Imaoka S: [A surgical case of solitary lymph node
metastatic recurrence of hepatocellular carcinoma after
hepatectomy]. Gan To Kagaku Ryoho. 33:1938–1940. 2006.PubMed/NCBI
|
|
12
|
Nakamura M, Nagano H, Wada H, Ota H,
Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Dono
K and Monden M: A case of hepatocellular carcinoma with multiple
lung, spleen, and remnant liver metastasis successfully treated by
combination chemotherapy with the novel oral DPD-inhibiting
chemotherapeutic drug S-1 and interferon-alpha. J Gastroenterol.
41:1120–1125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakamura M, Nagano H, Sakon M, Yamamoto T,
Ota H, Wada H, Yoshioka S, Kato H, Damdinsuren B, Marubashi S, et
al: [A case of HCC with inferior caval vein tumor thrombus and
multiple pulmonary metastases that remarkably responded to
combination therapy of TS-1 and interferon-alpha]. Gan To Kagaku
Ryoho. 32:1824–1828. 2005.PubMed/NCBI
|
|
14
|
Nakamura M, Nagano H, Sakon M, Kondo M,
Yamamoto T, Ota H, Wada H, Damdinsuren B, Yang Y, Marubashi S, et
al: [A case of long-term survivor with multiple pulmonary
metastases of HCC after hepatic resection]. Gan To Kagaku Ryoho.
31:1939–1942. 2004.PubMed/NCBI
|
|
15
|
Kanda Y, Akazawa S, Futatsugi K, Fujiki T,
Saifuku K, Yamamoto K, Suzuki F, Nakajima T, Naoi Y, Muraoka M, et
al: [A case of hepatocellular carcinoma (HCC) with lung metastasis
which responded to chemotherapy with a single use of
1-hexylcarbamoyl-5-fluorouracil (HCFU)]. Gan To Kagaku Ryoho.
16:269–272. 1989.PubMed/NCBI
|
|
16
|
Akita H, Marubashi S, Wada H, Hama N,
Kawamoto K, Kobayashi S, Eguchi H, Doki Y, Mori M and Nagano H:
Combination therapy with S-1 and interferon-α in hepatocellular
carcinoma patients with lung metastasis. Mol Clin Oncol. 3:322–328.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang S, Liu Y, Wang L, Duan C and Liu M:
A meta-analysis and systematic review: Adjuvant interferon therapy
for patients with viral hepatitis-related hepatocellular carcinoma.
World J Surg Oncol. 11:2402013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W, Song TQ, Zhang T, Wu Q, Kong DL,
Li Q and Sun HC: Adjuvant interferon for early or late recurrence
of hepatocellular carcinoma and mortality from hepatocellular
carcinoma following curative treatment: A meta-analysis with
comparison of different types of hepatitis. Mol Clin Oncol.
2:1125–1134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang TS, Shyu YC, Chen HY, Yuan SS, Shih
JN and Chen PJ: A systematic review and meta-analysis of adjuvant
interferon therapy after curative treatment for patients with viral
hepatitis-related hepatocellular carcinoma. J Viral Hepat.
20:729–743. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang S, Lin Q, Lin W, Hu W and Wang G:
Effect of adjuvant interferon therapy on hepatitis B virus-related
hepatocellular carcinoma: A systematic review. World J Surg Oncol.
14:1592016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Eun JR, Lee HJ, Moon HJ, Kim TN, Kim JW
and Chang JC: Hepatic arterial infusion chemotherapy using
high-dose 5-fluorouracil and cisplatin with or without
interferon-alpha for the treatment of advanced hepatocellular
carcinoma with portal vein tumor thrombosis. Scand J Gastroenterol.
44:1477–1486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Shea JJ, Schwartz DM, Villarino AV,
Gadina M, McInnes IB and Laurence A: The JAK-STAT pathway: Impact
on human disease and therapeutic intervention. Annu Rev Med.
66:311–328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Quiroga AD, de Lujan Alvarez M, Parody JP,
Ronco MT, Carnovale CE and Carrillo MC: Interferon-alpha2b
(IFN-alpha2b)-induced apoptosis is mediated by p38 MAPK in
hepatocytes from rat preneoplastic liver via activation of NADPH
oxidase. Growth Factors. 27:214–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Maeda S, Wada H, Naito Y, Nagano H,
Simmons S, Kagawa Y, Naito A, Kikuta J, Ishii T, Tomimaru Y, et al:
Interferon-α acts on the S/G2/M phases to induce apoptosis in the
G1 phase of an IFNAR2-expressing hepatocellular carcinoma cell
line. J Biol Chem. 289:23786–23795. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmeisser H, Bekisz J and Zoon KC: New
function of type I IFN: Induction of autophagy. J Interferon
Cytokine Res. 34:71–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Comet NR, Aguiló JI, Rathoré MG, Catalán
E, Garaude J, Uzé G, Naval J, Pardo J, Villalba M and Anel A: IFNα
signaling through PKC-θ is essential for antitumor NK cell
function. Oncoimmunology. 3:e9487052014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lapenta C, Donati S, Spadaro F, Castaldo
P, Belardelli F, Cox MC and Santini SM: NK cell activation in the
antitumor response induced by IFN-α dendritic cells loaded with
apoptotic cells from follicular lymphoma patients. J Immunol.
197:795–806. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hervas-Stubbs S, Mancheño U, Riezu-Boj JI,
Larraga A, Ochoa MC, Alignani D, Alfaro C, Morales-Kastresana A,
Gonzalez I, Larrea E, et al: CD8 T cell priming in the presence of
IFN-α renders CTLs with improved responsiveness to homeostatic
cytokines and recall antigens: Important traits for adoptive T cell
therapy. J Immunol. 189:3299–3310. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pacella I, Timperi E, Accapezzato D,
Martire C, Labbadia G, Cavallari EN, D'Ettorre G, Calvo L, Rizzo F,
Severa M, et al: IFN-α promotes rapid human Treg contraction and
late Th1-like Treg decrease. J Leukoc Biol. 100:613–623. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Zhu CP, Hu PF, Qian H, Ning BF,
Zhang Q, Chen F, Liu J, Shi B, Zhang X and Xie WF: FOXA2 suppresses
the metastasis of hepatocellular carcinoma partially through matrix
metalloproteinase-9 inhibition. Carcinogenesis. 35:2576–2583. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martin MD, Carter KJ, Jean-Philippe SR,
Chang M, Mobashery S, Thiolloy S, Lynch CC, Matrisian LM and
Fingleton B: Effect of ablation or inhibition of stromal matrix
metalloproteinase-9 on lung metastasis in a breast cancer model is
dependent on genetic background. Cancer Res. 68:6251–6259. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Wu WZ, Sun HC, Wu XF, Qin LX, Liu
YK, Liu KD and Tang ZY: Mechanism of interferon alpha on inhibition
of metastasis and angiogenesis of hepatocellular carcinoma after
curative resection in nude mice. J Gastrointest Surg. 7:587–594.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun HC, Tang ZY, Wang L, Qin LX, Ma ZC, Ye
QH, Zhang BH, Qian YB, Wu ZQ, Fan J, et al: Postoperative
interferon alpha treatment postponed recurrence and improved
overall survival in patients after curative resection of
HBV-related hepatocellular carcinoma: A randomized clinical trial.
J Cancer Res Clin Oncol. 132:458–465. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gong W, Zhang GM, Liu Y, Lei Z, Li D, Yuan
Y, Huang B and Feng ZH: IFN-gamma withdrawal after immunotherapy
potentiates B16 melanoma invasion and metastasis by intensifying
tumor integrin alphavbeta3 signaling. Int J Cancer. 123:702–708.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hiramatsu N, Yamada R and Takehara T: The
suppressive effect of nucleos(t)ide analogue treatment on the
incidence of hepatocellular carcinoma in chronic hepatitis B
patients. J Gastroenterol Hepatol. 31:546–552. 2016. View Article : Google Scholar : PubMed/NCBI
|
